• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞周期蛋白A-细胞周期蛋白依赖性激酶2复合物通过丝氨酸104和106的磷酸化增强人雌激素受体α的转录激活作用。

Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex.

作者信息

Rogatsky I, Trowbridge J M, Garabedian M J

机构信息

Department of Microbiology and the Kaplan Comprehensive Cancer Center, New York University School of Medicine, New York, New York 10016, USA.

出版信息

J Biol Chem. 1999 Aug 6;274(32):22296-302. doi: 10.1074/jbc.274.32.22296.

DOI:10.1074/jbc.274.32.22296
PMID:10428798
Abstract

Both estradiol binding and phosphorylation regulate transcriptional activation by the human estrogen receptor alpha (ER). We have previously shown that activation of the cyclin A-CDK2 complex by overexpression of cyclin A leads to enhanced ER-dependent transcriptional activation and that the cyclin A-CDK2 complex phosphorylates the ER N-terminal activation function-1 (AF-1) between residues 82 and 121. Within ER AF-1, serines 104, 106, and 118 represent potential CDK phosphorylation sites, and in this current study, we ascertain their importance in mediating cyclin A-CDK2-dependent enhancement of ER transcriptional activity. Cyclin A overexpression does not enhance transcriptional activation by an ER derivative bearing serine-to-alanine changes at residues 104, 106, and 118. Likewise, the cyclin A-CDK2 complex does not phosphorylate this triple-mutated derivative in vitro. Individual serine-to-alanine mutations at residues 104 and 106, but not 118, decrease ER-dependent transcriptional enhancement in response to cyclin A. The same relationship holds for ER phosphorylation by cyclin A-CDK2 in vitro. Finally, enhancement of ER transcriptional activation by cyclin A is evident in the absence and presence of estradiol, as well as in the presence of tamoxifen, suggesting that the effect of the cyclin A-CDK2 on ER transcriptional activation is AF-2-independent. These results indicate that the enhancement of ER transcriptional activation by the cyclin A-CDK2 complex is mediated via the AF-1 domain by phosphorylation of serines 104 and 106. We propose that these residues control ER AF-1 activity in response to signals that affect cyclin A-CDK2 function.

摘要

雌二醇结合和磷酸化均调节人雌激素受体α(ER)的转录激活。我们之前已经表明,通过过表达细胞周期蛋白A激活细胞周期蛋白A-CDK2复合物会导致ER依赖性转录激活增强,并且细胞周期蛋白A-CDK2复合物会使ER N端激活功能1(AF-1)在82至121位残基之间发生磷酸化。在ER AF-1中,丝氨酸104、106和118代表潜在的CDK磷酸化位点,在本研究中,我们确定它们在介导细胞周期蛋白A-CDK2依赖性增强ER转录活性中的重要性。在104、106和118位残基处带有丝氨酸到丙氨酸变化的ER衍生物,细胞周期蛋白A的过表达不会增强其转录激活。同样,细胞周期蛋白A-CDK2复合物在体外不会使这种三重突变衍生物发生磷酸化。在104和106位残基处的单个丝氨酸到丙氨酸突变(而非118位)会降低细胞周期蛋白A诱导的ER依赖性转录增强。体外细胞周期蛋白A-CDK2对ER的磷酸化也存在相同关系。最后,无论有无雌二醇以及是否存在他莫昔芬,细胞周期蛋白A均可增强ER转录激活,这表明细胞周期蛋白A-CDK2对ER转录激活的作用不依赖于AF-2。这些结果表明,细胞周期蛋白A-CDK2复合物对ER转录激活的增强是通过丝氨酸104和106的磷酸化经由AF-1结构域介导的。我们提出,这些残基响应影响细胞周期蛋白A-CDK2功能的信号来控制ER AF-1的活性。

相似文献

1
Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex.细胞周期蛋白A-细胞周期蛋白依赖性激酶2复合物通过丝氨酸104和106的磷酸化增强人雌激素受体α的转录激活作用。
J Biol Chem. 1999 Aug 6;274(32):22296-302. doi: 10.1074/jbc.274.32.22296.
2
Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex.细胞周期蛋白A/细胞周期蛋白依赖性激酶2复合物对雌激素受体转录增强的调控。
Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10132-7. doi: 10.1073/pnas.94.19.10132.
3
The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.细胞周期调控转录因子B-Myb在增强其反式激活特性的位点被细胞周期蛋白A/细胞周期蛋白依赖性激酶2磷酸化。
Oncogene. 1998 Nov 26;17(21):2679-89. doi: 10.1038/sj.onc.1202503.
4
Degradation of cyclin A does not require its phosphorylation by CDC2 and cyclin-dependent kinase 2.细胞周期蛋白A的降解并不需要其被细胞周期蛋白依赖性激酶2(CDC2)磷酸化。
J Biol Chem. 2000 Feb 4;275(5):3158-67. doi: 10.1074/jbc.275.5.3158.
5
BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site.在体内,BRCA1在细胞周期蛋白依赖性激酶2的磷酸化位点丝氨酸1497处发生磷酸化。
Mol Cell Biol. 1999 Jul;19(7):4843-54. doi: 10.1128/MCB.19.7.4843.
6
Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic).Notch(ic) 诱导细胞周期蛋白D1转录和CDK2活性:对Notch(ic)转化中细胞周期破坏的影响。
Mol Cell Biol. 2001 Sep;21(17):5925-34. doi: 10.1128/MCB.21.17.5925-5934.2001.
7
Identification of cyclin A/Cdk2 phosphorylation sites in B-Myb.B-Myb中细胞周期蛋白A/Cdk2磷酸化位点的鉴定
Eur J Biochem. 1999 Mar;260(2):384-91. doi: 10.1046/j.1432-1327.1999.00191.x.
8
Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.在G1-S期进程中,雌激素诱导的Cdk4和Cdk2激活伴随着细胞周期蛋白D1表达增加以及细胞周期蛋白依赖性激酶抑制剂与细胞周期蛋白E-Cdk2的结合减少。
J Biol Chem. 1997 Apr 18;272(16):10882-94. doi: 10.1074/jbc.272.16.10882.
9
Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization.细胞周期蛋白A/细胞周期蛋白依赖性激酶2对哺乳动物CDC6的磷酸化作用调控其亚细胞定位。
EMBO J. 1999 Jan 15;18(2):396-410. doi: 10.1093/emboj/18.2.396.
10
Phosphorylation of the myristoylated protein kinase C substrate MARCKS by the cyclin E-cyclin-dependent kinase 2 complex in vitro.细胞周期蛋白E-细胞周期蛋白依赖性激酶2复合物在体外对肉豆蔻酰化蛋白激酶C底物MARCKS的磷酸化作用。
Biochem J. 1999 Jun 15;340 ( Pt 3)(Pt 3):775-82.

引用本文的文献

1
Emerging opportunities to treat drug-resistant breast cancer: Discovery of novel small-molecule inhibitors against different targets.治疗耐药性乳腺癌的新机遇:针对不同靶点发现新型小分子抑制剂。
Front Pharmacol. 2025 Aug 29;16:1578342. doi: 10.3389/fphar.2025.1578342. eCollection 2025.
2
Mechanism and Predictive Role of NUB1 Protein in Oestrogen Receptor Pathway of FEC-Treated Breast Cancer Patients.NUB1蛋白在FEC治疗的乳腺癌患者雌激素受体通路中的作用机制及预测作用
Biomedicines. 2025 May 27;13(6):1307. doi: 10.3390/biomedicines13061307.
3
Loss function of tumor suppressor FRMD8 confers resistance to tamoxifen therapy via a dual mechanism.
肿瘤抑制因子FRMD8的缺失功能通过双重机制赋予对他莫昔芬治疗的抗性。
Elife. 2025 Apr 11;13:RP101888. doi: 10.7554/eLife.101888.
4
Hormone Signaling in Breast Development and Cancer.乳腺发育与癌症中的激素信号传导
Adv Exp Med Biol. 2025;1464:279-307. doi: 10.1007/978-3-031-70875-6_15.
5
Cell-cycle machinery is critical in regulating uterine steroid hormone for embryo implantation and development.细胞周期机制对于调节胚胎着床和发育所需的子宫甾体激素至关重要。
J Clin Invest. 2024 Nov 15;134(22):e186194. doi: 10.1172/JCI186194.
6
Uterine cyclin A2-deficient mice as a model of female early pregnancy loss.子宫细胞周期蛋白 A2 缺陷型小鼠作为雌性早期妊娠丢失模型。
J Clin Invest. 2024 Sep 12;134(22):e163796. doi: 10.1172/JCI163796.
7
Deciphering the Role of BCAR3 in Cancer Progression: Gene Regulation, Signal Transduction, and Therapeutic Implications.解读BCAR3在癌症进展中的作用:基因调控、信号转导及治疗意义
Cancers (Basel). 2024 Apr 26;16(9):1674. doi: 10.3390/cancers16091674.
8
CRISPR-Cas9 screen reveals a role of purine synthesis for estrogen receptor α activity and tamoxifen resistance of breast cancer cells.CRISPR-Cas9 筛选揭示嘌呤合成对于乳腺癌细胞中雌激素受体 α 活性和他莫昔芬耐药性的作用。
Sci Adv. 2023 May 12;9(19):eadd3685. doi: 10.1126/sciadv.add3685.
9
RNA interference analysis of potential functions of cyclin A in the reproductive development of male oriental river prawns ().细胞周期蛋白A在雄性日本沼虾生殖发育中潜在功能的RNA干扰分析()
Front Genet. 2022 Nov 17;13:1053826. doi: 10.3389/fgene.2022.1053826. eCollection 2022.
10
Estrogen receptor-α signaling in post-natal mammary development and breast cancers.雌激素受体-α在产后乳腺发育和乳腺癌中的信号转导。
Cell Mol Life Sci. 2021 Aug;78(15):5681-5705. doi: 10.1007/s00018-021-03860-4. Epub 2021 Jun 22.